In Vitro Activity of New β-Lactamase Inhibitor Combinations against <i>bla</i>_NDM, <i>bla</i>_KPC, and ESBL-Producing Enterobacteriales Uropathogens

• Autori principali: Lubna Razaq (Autore), Fakhur Uddin (Autore), Shahzad Ali (Autore), Shah Muhammad Abbasi (Autore), Muhammad Sohail (Autore), Nabila E. Yousif (Autore), Hala M. Abo-Dief (Autore), Zeinhom M. El-Bahy (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2023-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Antibiotic resistance in uropathogens has increased substantially and severely affected treatment of urinary tract infections (UTIs). Lately, some new formulations, including meropenem/vaborbactam (MEV), ceftazidime/avibactam (CZA), and ceftolozane/tazobactam (C/T) have been introduced to treat infe...